AbbVie Baxter Golden Cross: One Signal Proves Real
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Uncover the best high cash back cards that charge no annual fees. Maximize your rewards while keeping your costs down.
28,270 articlesTwo pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Rivian's upcoming R2 could expand its market appeal far beyond premium EVs. This article breaks down why investors ma...
Investors are buzzing after Simulations Plus announced a cash buyout at $18.50 per share. This deep-dive explains why...
Bitcoin moves back toward the $74,000 mark as sentiment flips to bullish. Analysts warn the rally could be fragile, b...
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
Bitcoin faces a fresh test as sentiment cools despite a modest near-term upside. Markets monitor whether BTC can recl...
The Department of Justice has waved through the Hart-Scott-Rodino review for the real brokerage remax merger, moving ...
Three practical lessons from SpaceX’s IPO can guide investors as Anthropic and OpenAI approach the market. Learn how ...
Industrial stocks right now offer solid exposure to infrastructure spending and manufacturing demand. Meet two top pi...
Blockchain tracker Lookonchain flags hype linked to Arthur Hayes as he denies fresh HYPE purchases after a roughly $2...
As rates stabilize in Q1 2026, loan officers are expanding beyond a single source to build a resilient pipeline by wo...
Ford kicked off the year with strong truck demand and a raised outlook. Now the automaker aims to sustain momentum in...